Product Description
There has been an increase in education on the benefits of anti-adhesive products. Adhesions can cause chronic pain, bowel obstruction and infertility, and it is more expensive to repair an adhesion once it has occurred then to prevent it by using an anti-adhesive product. Some surgeons believe that excellent surgical technique can prevent adhesions from occurring, and these products do not have enough supporting evidence behind them.
The anti-adhesion market, also referred to as the adhesion prevention market, includes products aimed at minimizing surgical adhesions. Surgical adhesions are fibrous bands that form between tissues and organs, often as a result of injury during surgery. These adhesions can be formed during any type of surgery, including gynecological, abdominal, orthopedic, cardiac and neurological procedures.
Segments Covered in This Market
- Total Anti-Adhesion Market
Report Data Types Included
- Unit Sales, Average Selling Prices, Market Value & Growth Trends
- 10 Year Scope (3 Year Historical + 7 Year Forecast Period)
- Market Drivers & Limiters for Each Segment
- Competitive Analysis with Market Shares
- Product Portfolios
- Related Press Releases from Top Competitors
Companies Analyzed
Of the many companies in the United States Anti-Adhesion market, Genzyme was the leader, followed by Ethicon and Baxter. Genzyme offers the Seprafilm® product. Seprafilm® is a combination of carboxymethylcellulose (CMC) and hyaluronic acid (HA), and it is the only product that large-scale clinical studies have shown to reduce not only adhesion formation, but also symptoms from adhesions. Ethicon sold the INTERCEED® (TC7) product, which is used in open (laparotomy) gynecological and pelvic surgeries. It is also more often used off-label than Seprafilm®. Baxter sells the Adept Adhesion Reduction Solution®. This product was the only liquid FDA-approved product on the market.
About Our In-Depth MedCore Research
Our analysts meticulously research for up to 3 to 4 months to put together one suite of reports (MedSuite), which is a comprehensive analysis on a group of healthcare markets. A MedCore is one portion of that analysis that focuses on one market segment, and provides further detailed segmentation to get a much more granular set of market data.
This MedCore is also found in the full report suite titled United States Market Report Suite for Wound and Tissue Management – MedSuite
